Back to search

Article

CDK5RAP3 as a Novel Biomarker Signature Predicting Survival and Adjuvant Chemotherapeutic benefit in Gastric Cancer

2020-12-21

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold>We previously demonstrated that CDK5RAP3 acts as a tumour suppressor in gastric cancer through negative regulation of the Wnt/β-catenin signalling pathway, but its function in chemotherapeutic responsiveness of gastric cancer has not been investigated. In this study, we aimed to examine the clinical significance of CDK5RAP3 to predict chemotherapeutic responsive...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
834d0d0b-71d5-5dad-8cfb-8e88c76c8d98
DOI
10.21203/rs.3.rs-130268/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
CDK5RAP3 as a Novel Biomarker Signature Predicting Survival and Adjuvant Chemotherapeutic benefit in Gastric CancerDOI 10.21203/rs.3.rs-130268/v1
Select a neighboring publication to make it the new centre.